01643.HK
Modern Chinese Medicine Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 0.33
−2.94%Year over year
Reported trailing growth
- Revenue
- -2.2%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -29.3%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +70.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026